A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma.
Phase of Trial: Phase II
Latest Information Update: 02 May 2012
At a glance
- Drugs Carboplatin; Paclitaxel; Sorafenib
- Indications Malignant melanoma
- Focus Therapeutic Use
- 22 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2009 Celgene Corporation as company and lead trial centre added as reported by ClinicalTrials.gov.
- 02 Aug 2007 New trial record.